Novo Nordisk reported DKK19.76B in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
Bausch Health Companies USD 616M 11M Sep/2025
Bristol-Myers Squibb USD 4.29B 1.14B Sep/2025
Eli Lilly USD 4.26B 186.5M Sep/2025
GlaxoSmithKline GBP 15.68B 855M Sep/2025
Merck USD 4.15B 102M Sep/2025
Novartis USD 4.56B 49M Sep/2025
Novo Nordisk DKK 19.76B 4.15B Dec/2025
Novo Nordisk DKK 4.46B 15.12B Jun/2025
Pacira USD 17.69M 12.44M Sep/2025
Sanofi EUR 22.93B 927M Dec/2025
Supernus Pharmaceuticals USD 108.61M 100.4M Sep/2025